Adaptive Biotechnologies
ADPT
ADPT
190 hedge funds and large institutions have $457M invested in Adaptive Biotechnologies in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 56 increasing their positions, 69 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 37
35% less capital invested
Capital invested by funds: $709M → $457M (-$251M)
98% less call options, than puts
Call options by funds: $12K | Put options by funds: $581K
Holders
190
Holding in Top 10
2
Calls
$12K
Puts
$581K
Top Buyers
| 1 | +$24.5M | |
| 2 | +$2.68M | |
| 3 | +$2.54M | |
| 4 |
Cerity Partners
New York
|
+$1.74M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.34M |
Top Sellers
| 1 | -$11.1M | |
| 2 | -$7.21M | |
| 3 | -$5.95M | |
| 4 |
Morgan Stanley
New York
|
-$3.91M |
| 5 |
ECM
ExodusPoint Capital Management
New York
|
-$3.74M |